Why Is CHRONOSCALE HOLDINGS (CHRN) Stock Down Today?
By the Top Tier Newswire AI Desk · November 18, 2026 at 9:38 AM ET · reviewed against 5 wire stories
CHRONOSCALE HOLDINGS (CHRN) is down -9.03% in the latest session. Our newswire has captured 5 stories on CHRN across 4 sources in the last 36 hours, with AI sentiment reading mixed (avg 55/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
ChronoScale Holdings (CHRN) shares fell 9.03% to $8.86, driven by a new development partnership and a significant capital raise. The company announced a collaboration with STN to develop a data center campus in Texas, aiming to accelerate AI compute capacity deployment.
What Happened
ChronoScale filed an 8-K with the SEC on November 18, 2026, disclosing the entry into a material definitive agreement. The filing detailed a partnership with STN for the development of a data center campus in Texas. The initial deployment is designated for a leading frontier AI lab and carries a total contract value of $7.5 billion over six years. The company also disclosed the creation of a direct financial obligation as part of this arrangement.
The stock had previously been involved in a corporate restructuring, completing the sale of its Ekso Bionics business unit. Ekso Bionics Holdings subsequently changed its ticker symbol to CHRN. The company recently reported fiscal Q1 2027 financial results and filed a $500 million mixed shelf registration.
What The Data Shows
The stock opened at $10.00, a 2.7% gap up from the prior close of $9.74. It reached a session high of $10.00 at 8:30 AM ET before sliding to a session low of $8.86 at 9:35 AM ET. Volume stood at 0.0M shares, which is 0.2x the three-month daily average.
Fundamentals indicate a market cap of $1.4B. The company is unprofitable with a trailing twelve-month EPS of -0.46. Revenue declined 15.1% over the trailing twelve months, and the net margin is -84.6%. The stock has a beta of 1.10 and a 52-week range of $3.50 to $30.00. Over the last eight sessions, the stock moved -9.4%, declining from $10.75 to $9.74. The stock printed three fresh 52-week lows on November 18, 2026.
What To Watch
Investors will monitor the execution of the $7.5 billion contract and the impact of the new capital raise on the company's balance sheet.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Filed: 2026-11-18 AccNo: 0001493152-26-052998 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 8.01: Other Events Item 9.01: Financial Statements and…
2d agoBusiness InsiderBULLISH 74Product/PR
ChronoScale Announces New Development Partnership to Accelerate AI Compute Capacity Deployment, Supported by a Significant Capital Raise
Initial deployment for a leading frontier AI lab The initial deployment carries a total contract value of $7.5 billion over six years
2d agoInvesting.com MarketsBEARISH 38General
Why is Chronoscale stock sliding today?
Why is Chronoscale stock sliding today?
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →